Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B Gallery

Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B

Vivo Capital Appoints New Managing Partners and Partners Gallery

Vivo Capital Appoints New Managing Partners and Partners

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China Gallery

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

Serán Bioscience Announces Investment by Vivo Capital Gallery

Serán Bioscience Announces Investment by Vivo Capital

Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D Gallery

Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies Gallery

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies

Swift Health Systems Raises $45 Million in Series C Funding Gallery

Swift Health Systems Raises $45 Million in Series C Funding

Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities Gallery

Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities

Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million Gallery

Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million

Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China Gallery

Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China

Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China Gallery

Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China